ASSOCIATION OF SGLT2 INHIBITORS WITH STROKE IN PATIENTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Mi, D. [1 ]
Pan, P. [1 ]
Chen, S. [1 ]
Chen, S. [1 ]
Peng, F. [1 ]
机构：
[1] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF STROKE | 2024年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
SO067 / #
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [21] Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis
    Naveen C. Hegde
    Ankit Kumar
    Amol N. Patil
    Samiksha Bhattacharjee
    Nanda Gamad
    Kripa Shanker Kasudhan
    Vivek Kumar
    Ashu Rastogi
    Acta Diabetologica, 2023, 60 : 1311 - 1331
  • [22] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Li, Wen-jie
    Chen, Xing-qing
    Xu, Ling-ling
    Li, Yuan-qing
    Luo, Bi-hui
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [23] SGLT2 INHIBITORS COMPARED WITH SITAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Sevald, C. A.
    Jackson, J. D.
    Mcana, J. F.
    VALUE IN HEALTH, 2016, 19 (03) : A197 - A197
  • [24] SGLT2 Inhibitors versus Sulfonylureas as Add-On Therapy to Metformin in Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Umer, Muhammed
    Salman, Ali
    Nadeem, Shahrukh
    Iqbal, Abiha
    Tashrifwala, Fatema
    Paryani, Neha Saleem
    Ali, Eman
    Kumar, Jai
    Maniya, Muhammad Talha
    Asad, Dayab
    CIRCULATION, 2023, 148
  • [25] SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
    Elisa Marilly
    Judith Cottin
    Natalia Cabrera
    Catherine Cornu
    Remy Boussageon
    Philippe Moulin
    Jean-Christophe Lega
    François Gueyffier
    Michel Cucherat
    Guillaume Grenet
    Diabetologia, 2022, 65 : 2000 - 2010
  • [26] Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Type 1 Diabetes: A Systematic Review and Meta-analysis
    El Masri, Dana
    Jaber, Linda
    DIABETES, 2017, 66 : LB41 - LB41
  • [27] SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
    Marilly, Elisa
    Cottin, Judith
    Cabrera, Natalia
    Cornu, Catherine
    Boussageon, Remy
    Moulin, Philippe
    Lega, Jean-Christophe
    Gueyffier, Francois
    Cucherat, Michel
    Grenet, Guillaume
    DIABETOLOGIA, 2022, 65 (12) : 2000 - 2010
  • [28] Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Xin Wang
    Fengyi Zhang
    Yufeng Zhang
    Jiayi Zhang
    Yingli Sheng
    Wenbo Wang
    Yujie Li
    Osteoporosis International, 2023, 34 : 2013 - 2025
  • [29] Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
    Yang, Shiwen
    Liu, Ying
    Zhang, Shengzhao
    Wu, Fengbo
    Liu, Dan
    Wu, Qingfang
    Zheng, Hanrui
    Fan, Ping
    Su, Na
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Pharmacological selectivity of SGLT2 inhibitors and cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis
    Sayour, A. A.
    Olah, A.
    Ruppert, M.
    Barta, B. A.
    Benke, K.
    Merkely, B.
    Radovits, T.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2688 - 2688
12345